← Leaderboards
Anna Degraff Tischler
University Of Minnesota
$4,782,782
Attributed
$4,991,255
Total exposure
8
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2013–25$2.5M$1.9M$1.3M$625K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,991,255 · 8
By mechanism
R21$2,764,076 · 7
DP2$2,227,179 · 1
Top collaborators
- Yuying Liang2 shared
Most similar at University Of Minnesota
Same institution · by research overlap
- Yuying Liang$5,110,790
- Courtney C Aldrich$9,602,262
- Mark R. Schleiss$10,248,102
- Craig John Bierle$2,400,280
Others in their field
Top investigators on “Mycobacterium Tuberculosis”
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$267,251,837
- Constance Ann Benson · University Of California, San Diego$150,079,712
- Kevin Urdahl · Seattle Children'S Hospital$86,597,961
- David Alland · Rutgers Biomedical And Health Sciences$70,943,567
- Sarah Fortune · Harvard School Of Public Health$51,119,645
- William Robert Jacobs · Albert Einstein College Of Medicine$43,123,310
Research focus
Mycobacterium TuberculosisTuberculosisInfectionInnovationMutantIn VitroGrowthMissionAerosolsPreventTuberculosis DrugsProteinsDrug TargetingMacrophagePathogenChronic InfectionUnited States National Institutes Of HealthLungFutureNutrientDrug DevelopmentChronicCessation Of LifeNovel Therapeutics
Grant awards (13)
Myobacterium tuberculosis Phenylalanine Synthesis as a Novel Drug Target$423,500
R21 · FY2025 · AI · contact PI
Riboflavin Synthesis and Transport in Mycobacterium tuberculosis$231,000
R21 · FY2025 · AI · contact PI
Novel multivalent viral vectored tuberculosis vaccines targeting lung immunity$227,848
R21 · FY2024 · AI · contact PI
Novel multivalent viral vectored tuberculosis vaccines targeting lung immunity$189,098
R21 · FY2023 · AI · contact PI
In vivo Reporters of Mycobacterium tuberculosis ESX-5 Secretion$193,750
R21 · FY2022 · AI · contact PI
PPE Export by the Essential ESX-5 Secretion System in M. tuberculosis Virulence$193,750
R21 · FY2022 · AI · contact PI
In vivo Reporters of Mycobacterium tuberculosis ESX-5 Secretion$232,500
R21 · FY2021 · AI · contact PI
PPE Export by the Essential ESX-5 Secretion System in M. tuberculosis Virulence$232,500
R21 · FY2021 · AI · contact PI
Redefining Mycobacterium tuberculosis genes essential for infection$193,229
R21 · FY2021 · AI · contact PI
Redefining Mycobacterium tuberculosis genes essential for infection$231,000
R21 · FY2020 · AI · contact PI
Identifying M. tuberculosis ESX-5 Secreted Substrates Required for Virulence.$189,120
R21 · FY2019 · AI · contact PI
Identifying M. tuberculosis ESX-5 Secreted Substrates Required for Virulence.$226,781
R21 · FY2018 · AI · contact PI
High-Throughput Identification of Mycobacterium tuberculosis Persistence Mechanis$2,227,179
DP2 · FY2013 · AI · contact PI